Noxopharm Limited (ASX: NOX)
Sector: Health Care
Market cap: A$15M (as of 29 Oct 2026)
Noxopharm Limited (ASX:NOX) is an Australian clinical-stage drug development company focused on the treatment of cancer and cytokine release syndrome (septic shock).
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 13 Oct 2025 | MILLIGENE PTY LTD (THE GE + PR KELLY FAM TRUST) AND OTHERS | Entry | ?% → 11.72% | Filing ↗ |
| 29 Sept 2025 | MILLIGENE PTY LTD (THE GE + PR KELLY FAM TRUST) AND OTHERS | Entry | ?% → 11.72% | Filing ↗ |
| 30 Sept 2024 | MILLIGENE PTY LTD (THE GE + PR KELLY FAM TRUST) AND OTHERS | Entry | ?% → 11.72% | Filing ↗ |
| 27 Sept 2024 | MILLIGENE PTY LTD (THE GE + PR KELLY FAM TRUST) AND OTHERS | Entry | ?% → 11.72% | Filing ↗ |
| 30 Aug 2024 | Eleanore Goodridge | Exit | — | Filing ↗ |
Director trades — on-market
| Date | Director | Trade | Source |
|---|---|---|---|
| 15 Sept 2023 | FRED BART | Bought 880 - ORDINARY FULLY PAID SHARES | Filing ↗ |
| 14 Sept 2023 | FRED BART | Bought 253,001 shares | Filing ↗ |
| 30 June 2023 | FRED BART | Bought 135,281 ORDINARY FULLY PAID SHARES | Filing ↗ |
| 9 May 2023 | FRED BART | Bought 500,000 - ORDINARY FULLY PAID SHARES | Filing ↗ |
| 4 May 2023 | FRED BART | Bought 1,000,000 ORDINARY FULLY PAID SHARES | Filing ↗ |
Cash and runway
Ask about NOX in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has NOX raised money in the last year, and at what discount?
- What was NOX's latest cash position and runway?
Loading NOX…